Role of eicosanoids in PAF‐induced increases of the vascular permeability in rat airways
Open Access
- 1 December 1990
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 101 (4) , 896-900
- https://doi.org/10.1111/j.1476-5381.1990.tb14177.x
Abstract
1 Platelet activating factor (PAF; 1.0 and 5.0 μg kg−1) injected in the tail vein of unanaesthetized rats dose-dependently increased the vascular permeability of the trachea, upper and lower bronchi (up to 400%) as measured by the extravasation of Evans blue dye. The permeability of the parenchyma was not affected by PAF treatment. 2 Pretreatment of the animals with an intravenous injection of the PAF antagonist BN-52021 (10 mg kg−1) abolished almost totally the vascular permeability changes elicited by PAF injection (5.0 μg kg−1). 3 Pretreatment of the animals with intravenous injections of inhibitors of thromboxane formation, indomethacin (10 mg kg−1) and compound OKY-046 (10 mg kg−1), and thromboxane antagonist, compound L-655,240 (5 mg kg−1), partially reduced PAF effects in the airways (from 28 to 69%). The thromboxane mimic U-44069 (5.0 μg kg−1) did not modify the vascular permeability of rat airways. The effect of a low dose of PAF (0.1 μg kg−1) on the vascular permeability of the trachea and bronchi (but not of the parenchyma) was potentiated by compound U-44069 (5.0 μg kg−1) or noradrenaline (400 ng kg−1) whereas the effect of a high dose of PAF (5.0 μg kg−1) was not affected. 4 Neither the peptidoleukotriene antagonist MK-571 (10 mg kg−1) nor the 5-lipoxygenase inhibitor, L-663,536 (10 mg kg−1) given before the injection of PAF (5.0 μg kg−1) affected the protein extravasation in rat lung tissues. 5 These data suggest that the effect of PAF on rat vascular permeability is partly modulated by thromboxane formation although thromboxanes have no direct effect on the permeability. Thromboxane may act via a vasoconstriction that increases hydrostatic pressure and potentiates the extravasation elicited by PAF effect on endothelial cells. 6 Leukotrienes do not appear to be involved in the changes of rat airway permeability induced by PAF.This publication has 21 references indexed in Scilit:
- Human platelets modulate edema formation in isolated rabbit lungs.Journal of Clinical Investigation, 1989
- L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitorCanadian Journal of Physiology and Pharmacology, 1989
- Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchiEuropean Journal of Pharmacology, 1987
- Evidence for distinct systemic extravasation effects of platelet activating factor, leukotrienes B4, C4, D4 and histamine in the guinea pigProstaglandins, Leukotrienes and Medicine, 1986
- Effect of platelet activating factor on endothelial permeability to plasma macromoleculesImmunopharmacology, 1984
- Characteristics of the binding of platelet-activating factor to platelets of different animal speciesEuropean Journal of Pharmacology, 1984
- Acute microvascular effects of PAF-acether, as studied by intravital microscopyEuropean Journal of Pharmacology, 1983
- Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.Journal of Clinical Investigation, 1983
- Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.Proceedings of the National Academy of Sciences, 1981
- STUDIES ON INFLAMMATIONThe Journal of cell biology, 1961